|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Luo C, Lei T, Zhao M, Meng Q and Zhang M:
CD40 is positively correlated with the expression of nucleophosmin
in cisplatin-resistant bladder cancer. J Oncol. 2020:36767512020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Knowles MA and Hurst CD: Molecular biology
of bladder cancer: New insights into pathogenesis and clinical
diversity. Nat Rev Cancer. 15:25–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kristensen LS, Hansen TB, Venø MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tong Y, Liu X, Xia D, Peng E, Yang X, Liu
H, Ye T, Wang X, He Y, Xu H, et al: Biological roles and clinical
significance of exosome-derived noncoding RNAs in bladder cancer.
Front Oncol. 11:7047032021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang H, Xiao X, Wei W, Huang C, Wang M,
Wang L, He Y, Sun J, Jiang Y, Jiang G and Zhang X: CircLIFR
synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73
axis in bladder cancer. Mol Cancer. 20:702021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie F, Li Y, Wang M, Huang C, Tao D, Zheng
F, Zhang H, Zeng F, Xiao X and Jiang G: Circular RNA BCRC-3
suppresses bladder cancer proliferation through miR-182-5p/p27
axis. Mol Cancer. 17:1442018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeng Y, Du WW, Wu Y, Yang Z, Awan FM, Li
X, Yang W, Zhang C, Yang Q, Yee A, et al: A circular RNA binds to
and activates AKT phosphorylation and nuclear localization reducing
apoptosis and enhancing cardiac repair. Theranostics. 7:3842–3855.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Legnini I, Di Timoteo G, Rossi F, Morlando
M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade
M, et al: Circ-ZNF609 is a circular RNA that can be translated and
functions in myogenesis. Mol Cell. 66:22–37.e9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bromberg JF, Wrzeszczynska MH, Devgan G,
Zhao Y, Pestell RG, Albanese C and Darnell JE Jr: Stat3 as an
oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huynh J, Etemadi N, Hollande F, Ernst M
and Buchert M: The JAK/STAT3 axis: A comprehensive drug target for
solid malignancies. Semin Cancer Biol. 45:13–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mirzaei S, Gholami MH, Mahabady MK, Nabavi
N, Zabolian A, Banihashemi SM, Haddadi A, Entezari M, Hushmandi K,
Makvandi P, et al: Pre-clinical investigation of STAT3 pathway in
bladder cancer: Paving the way for clinical translation. Biomed
Pharmacother. 133:1110772021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hindupur SV, Schmid SC, Koch JA, Youssef
A, Baur EM, Wang D, Horn T, Slotta-Huspenina J, Gschwend JE, Holm
PS and Nawroth R: STAT3/5 inhibitors suppress proliferation in
bladder cancer and enhance oncolytic adenovirus therapy. Int J Mol
Sci. 21:11062020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhong Z, Lv M and Chen J: Screening
differential circular RNA expression profiles reveals the
regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in
bladder carcinoma. Sci Rep. 6:309192016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Zheng F, Xiao X, Xie F, Tao D, Huang
C, Liu D, Wang M, Wang L, Zeng F and Jiang G: CircHIPK3 sponges
miR-558 to suppress heparanase expression in bladder cancer cells.
EMBO Rep. 18:1646–1659. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu M, Wang Q, Shen J, Yang BB and Ding X:
Circbank: A comprehensive database for circRNA with standard
nomenclature. RNA Biol. 16:899–905. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dudekula DB, Panda AC, Grammatikakis I, De
S, Abdelmohsen K and Gorospe M: CircInteractome: A web tool for
exploring circular RNAs and their interacting proteins and
microRNAs. RNA Biol. 13:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McGeary SE, Lin KS, Shi CY, Pham TM,
Bisaria N, Kelley GM and Bartel DP: The biochemical basis of
microRNA targeting efficacy. Science. 366:eaav17412019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng J, Xiang W, Zhang Y, Huang C, Chen K
and Chen Z: Ubiquitous expressed transcript promotes tumorigenesis
by acting as a positive modulator of the polycomb repressive
complex 2 in clear cell renal cell carcinoma. BMC Cancer.
19:8742019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu CY and Kuo HC: The emerging roles and
functions of circular RNAs and their generation. J Biomed Sci.
26:292019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi DM, Li LX, Bian XY, Shi XJ, Lu LL,
Zhou HX, Pan TJ, Zhou J, Fan J and Wu WZ: miR-296-5p suppresses EMT
of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3
signaling. J Exp Clin Cancer Res. 37:2942018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang C, Zhao T, Li H, He F, Zhao X, Zhang
Y, Chu X, Hua C, Qu Y, Duan Y, et al: Long non-coding RNA ITIH4-AS1
accelerates the proliferation and metastasis of colorectal cancer
by activating JAK/STAT3 signaling. Mol Ther Nucleic Acids.
18:183–193. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Zhang Y, Song H, Yin H, Jiang T,
Xu Y, Liu L, Wang H, Gao H, Wang R and Song J: The circular RNA
circSPARC enhances the migration and proliferation of colorectal
cancer by regulating the JAK/STAT pathway. Mol Cancer. 20:812021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Berman HM, Westbrook J, Feng Z, Gilliland
G, Bhat TN, Weissig H, Shindyalov IN and Bourne PE: The protein
data bank. Nucleic Acids Res. 28:235–242. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun K, Wang D, Yang BB and Ma J: The
emerging functions of circular RNAs in bladder cancer. Cancers
(Basel). 13:46182021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Su Y, Feng W, Shi J, Chen L, Huang J and
Lin T: circRIP2 accelerates bladder cancer progression via
miR-1305/Tgf-β2/smad3 pathway. Mol Cancer. 19:232020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Wu H, Chu F, Zhang L and Xiao X:
Knockdown of circ_0000512 inhibits cell proliferation and promotes
apoptosis in colorectal cancer by regulating miR-296-5p/RUNX1 axis.
Onco Targets Ther. 13:7357–7368. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou Y, Liu X, Lan J, Wan Y and Zhu X:
Circular RNA circRPPH1 promotes triple-negative breast cancer
progression via the miR-556-5p/YAP1 axis. Am J Transl Res.
12:6220–6234. 2020.PubMed/NCBI
|
|
34
|
Zhao C, Li L, Li Z, Xu J, Yang Q, Shi P,
Zhang K and Jiang R: A novel circular RNA hsa_circRPPH1_015 exerts
an oncogenic role in breast cancer by impairing miRNA-326-Mediated
ELK1 inhibition. Front Oncol. 10:9062020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiong JW, Song SB, Xiong LM, Duan CH, Song
Q, Yu DL and Zhang XQ: CircRPPH1 promotes cell proliferation,
migration and invasion of non-small cell lung cancer via the
PI3K/AKT and JAK2/STAT3 signaling axes. J Biochem. 171:245–252.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rong D, Lu C, Zhang B, Fu K, Zhao S, Tang
W and Cao H: CircPSMC3 suppresses the proliferation and metastasis
of gastric cancer by acting as a competitive endogenous RNA through
sponging miR-296-5p. Mol Cancer. 18:252019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Savi F, Forno I, Faversani A, Luciani A,
Caldiera S, Gatti S, Foa P, Ricca D, Bulfamante G, Vaira V and
Bosari S: miR-296/Scribble axis is deregulated in human breast
cancer and miR-296 restoration reduces tumour growth in vivo. Clin
Sci (Lond). 127:233–242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han W, Kong D, Lu Q, Zhang W and Fan Z:
Aloperine inhibits proliferation and promotes apoptosis in
colorectal cancer cells by regulating the
circNSUN2/miR-296-5p/STAT3 pathway. Drug Des Devel Ther.
15:857–870. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang L, Liu Z, Ma J, Wang H, Gao D, Zhang
C and Ma Q: CircRPPH1 serves as a sponge for miR-296-5p to enhance
progression of breast cancer by regulating FOXP4 expression. Am J
Transl Res. 13:7556–7573. 2021.PubMed/NCBI
|
|
40
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shen M, Xu Z, Xu W, Jiang K, Zhang F, Ding
Q, Xu Z and Chen Y: Inhibition of ATM reverses EMT and decreases
metastatic potential of cisplatin-resistant lung cancer cells
through JAK/STAT3/PD-L1 pathway. J Exp Clin Cancer Res. 38:1492019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jin W: Role of JAK/STAT3 signaling in the
regulation of metastasis, the transition of cancer stem cells, and
chemoresistance of cancer by epithelial-mesenchymal transition.
Cells. 9:2172020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo H, Liu J, Ben Q, Qu Y, Li M, Wang Y,
Chen W and Zhang J: The aspirin-induced long non-coding RNA OLA1P2
blocks phosphorylated STAT3 homodimer formation. Genome Biol.
17:242016. View Article : Google Scholar : PubMed/NCBI
|
